文献速递慢阻肺哮喘

1990-2015年全球慢阻肺与哮喘疾病负担的系统分析

Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
PubMed 文献 · Lancet Respir Med · 2017-08-16

该研究基于GBD 2015,用CODEm与DisMod-MR 2.1估算1990-2015年188个国家的慢阻肺和哮喘死亡、患病与DALY。哮喘患病人数为慢阻肺两倍,慢阻肺死亡为哮喘八倍。

要点

  • 2015年哮喘患病人数为慢阻肺两倍,慢阻肺死亡为哮喘八倍。

核心结论

  • 2015年哮喘为全球最常见慢性呼吸病,患病人数为慢阻肺两倍,而慢阻肺死亡为哮喘八倍。

研究设计与样本

  • GBD 2015系统分析,覆盖188个国家1990-2015年数据。
  • 死亡用CODEm建模,患病与发病用DisMod-MR 2.1贝叶斯meta回归估算。
  • 慢阻肺采用GOLD肺功能定义,哮喘定义为报告诊断且伴当前喘息。

主要发现

  • 慢阻肺年龄标化DALY率随SDI升至中段后骤降;哮喘DALY率随SDI升高单调下降。

关键数值与推荐

  • 吸烟与室外颗粒物为慢阻肺主要风险,其后为家庭空气污染、职业颗粒物、臭氧和二手烟。

临床怎么用

  • 可按SDI分层理解各国慢阻肺与哮喘负担差异及趋势。
  • 防控应优先针对吸烟、室外与家庭空气污染等可干预风险。
  • 因病例定义与严重度测量无共识,跨国与跨期比较需谨慎。
  • 慢阻肺死亡绝对数受人口增长与老龄化抵消年龄标化率下降。

局限性

  • 原文指出人群健康测量中哮喘与慢阻肺病例定义及严重度测量尚无共识。
  • 部分国家生命登记不完整或缺失,需依赖协变量模型预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstructive pulmonary disease (COPD) and asthma are common diseases with a heterogeneous distribution worldwide. Here, we present methods and disease and risk estimates for COPD and asthma from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2015 study. The GBD study provides annual updates on estimates of deaths, prevalence, and disability-adjusted life years (DALYs), a summary measure of fatal and non-fatal disease outcomes, for over 300 diseases and injuries, for 188 countries from 1990 to the most recent year. METHODS: We estimated numbers of deaths due to COPD and asthma using the GBD Cause of Death Ensemble modelling (CODEm) tool. First, we analysed data from vital registration and verbal autopsy for the aggregate category of all chronic respiratory diseases. Subsequently, models were run for asthma and COPD relying on covariates to predict rates in countries that have incomplete or no vital registration data. Disease estimates for COPD and asthma were based on systematic reviews of published papers, unpublished reports, surveys, and health service encounter data from the USA. We used the Global Initiative of Chronic Obstructive Lung Disease spirometry-based definition as the reference for COPD and a reported diagnosis of asthma with current wheeze as the definition of asthma. We used a Bayesian meta-regression tool, DisMod-MR 2.1, to derive estimates of prevalence and incidence. We estimated population-attributable fractions for risk factors for COPD and asthma from exposure data, relative risks, and a theoretical minimum exposure level. Results were stratified by Socio-demographic Index (SDI), a composite measure of income per capita, mean years of education over the age of 15 years, and total fertility rate. FINDINGS: In 2015, 3·2 million people (95% uncertainty interval [UI] 3·1 million to 3·3 million) died from COPD worldwide, an increase of 11·6% (95% UI 5·3 to 19·8) compared with 1990. There was a decrease in age-standardised death rate of 41·9% (37·7 to 45·1) but this was counteracted by population growth and ageing of the global population. From 1990 to 2015, the prevalence of COPD increased by 44·2% (41·7 to 46·6), whereas age-standardised prevalence decreased by 14·7% (13·5 to 15·9). In 2015, 0·40 million people (0·36 million to 0·44 million) died from asthma, a decrease of 26·7% (-7·2 to 43·7) from 1990, and the age-standardised death rate decreased by 58·8% (39·0 to 69·0). The prevalence of asthma increased by 12·6% (9·0 to 16·4), whereas the age-standardised prevalence decreased by 17·7% (15·1 to 19·9). Age-standardised DALY rates due to COPD increased until the middle range of the SDI before reducing sharply. Age-standardised DALY rates due to asthma in both sexes decreased monotonically with rising SDI. The relation between with SDI and DALY rates due to asthma was attributed to variation in years of life lost (YLLs), whereas DALY rates due to COPD varied similarly for YLLs and years lived with disability across the SDI continuum. Smoking and ambient particulate matter were the main risk factors for COPD followed by household air pollution, occupational particulates, ozone, and secondhand smoke. Together, these risks explained 73·3% (95% UI 65·8 to 80·1) of DALYs due to COPD. Smoking and occupational asthmagens were the only risks quantified for asthma in GBD, accounting for 16·5% (14·6 to 18·7) of DALYs due to asthma. INTERPRETATION: Asthma was the most prevalent chronic respiratory disease worldwide in 2015, with twice the number of cases of COPD. Deaths from COPD were eight times more common than deaths from asthma. In 2015, COPD caused 2·6% of global DALYs and asthma 1·1% of global DALYs. Although there are laudable international collaborative efforts to make surveys of asthma and COPD more comparable, no consensus exists on case definitions and how to measure disease severity for population health measurements like GBD. Comparisons between countries and over time are important, as much of the chronic respiratory burden is either preventable or treatable with affordable interventions. FUNDING: Bill & Melinda Gates Foundation.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017. PMID: 28822787. doi:10.1016/S2213-2600(17)30293-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。